Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment

By Hultdin Magnus   Sundström Gunnel   Wahlin Anders   Lundström Berith   Samuelsson Jan   Birgegård Gunnar   Engström-Laurent Anna  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 63-70

Humana Press, Inc

Access to resources Recommend Favorite

Homoharringtonine is an effective therapy for patients with polycythemia vera or essential thrombocythemia who have failed or were intolerant to hydroxycarbamide or interferon-α therapy

By Li Yufeng   Zhu Jiabin   Ding Banghe  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 922-926

Springer Publishing Company

Access to resources Recommend Favorite

Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 14-29

Bentham Science Publishers

Access to resources Recommend Favorite

Decreased plasma decorin levels following acute ischemic stroke: Correlation with MMP-2 and differential expression in TOAST subtypes

By              

Molecular Medicine Reports, Vol. 6, Iss. 6, 2012-01 ,pp. : 1319-1324

Spandidos Publications

Access to resources Recommend Favorite

Decreased expression levels of Nurr1 are associated with chronic inflammation in patients with type 2 diabetes

By                    

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5487-5493

Spandidos Publications

Access to resources Recommend Favorite